The Global Landscape of TAVR Newcomers

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

The Self-expanding Single-operator CENTERA TAVR System

The Venus A and Venibri TAVR Systems – Better for Bicuspids and Dry Leaflet Technology

The Anatomically “Correct” JenaValve TAVR System – Pure AR Treatment

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Industry Perspective on Real-World Evidence for TAVR Outcomes – Where are the Opportunities?

PORTICO TAVR – Technology Review and Clinical Program Updates